133 related articles for article (PubMed ID: 36881770)
1. Utilization of NKX3.1, P501S, Prostate-Specific Antigen, and Steroidogenic Factor 1 to Distinguish Malignant Leydig Cell Tumor From Metastatic Prostatic Adenocarcinoma to the Testis.
Erak E; Ulbright TM; Epstein J
Arch Pathol Lab Med; 2023 Dec; 147(12):1458-1460. PubMed ID: 36881770
[TBL] [Abstract][Full Text] [Related]
2. NKX3.1 and Prostein Expression in Testicular Tissue and Sex Cord-stromal Tumors.
Arnesen C; Eich ML; Pena MDCR; Cappel JR; Schwartz L; Rais-Bahrami S; Faraj SF; Prieto Granada C; Gordetsky JB
Am J Surg Pathol; 2020 Jan; 44(1):61-67. PubMed ID: 31498176
[TBL] [Abstract][Full Text] [Related]
3. The role of P501S and PSA in the diagnosis of metastatic adenocarcinoma of the prostate.
Sheridan T; Herawi M; Epstein JI; Illei PB
Am J Surg Pathol; 2007 Sep; 31(9):1351-5. PubMed ID: 17721190
[TBL] [Abstract][Full Text] [Related]
4. NKX3.1 as a marker of prostatic origin in metastatic tumors.
Gurel B; Ali TZ; Montgomery EA; Begum S; Hicks J; Goggins M; Eberhart CG; Clark DP; Bieberich CJ; Epstein JI; De Marzo AM
Am J Surg Pathol; 2010 Aug; 34(8):1097-105. PubMed ID: 20588175
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical expression of prostatic antigens in adenocarcinoma and villous adenoma of the urinary bladder.
Lane Z; Hansel DE; Epstein JI
Am J Surg Pathol; 2008 Sep; 32(9):1322-6. PubMed ID: 18670358
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical differentiation of high-grade prostate carcinoma from urothelial carcinoma.
Chuang AY; DeMarzo AM; Veltri RW; Sharma RB; Bieberich CJ; Epstein JI
Am J Surg Pathol; 2007 Aug; 31(8):1246-55. PubMed ID: 17667550
[TBL] [Abstract][Full Text] [Related]
7. Best practices recommendations in the application of immunohistochemistry in the prostate: report from the International Society of Urologic Pathology consensus conference.
Epstein JI; Egevad L; Humphrey PA; Montironi R;
Am J Surg Pathol; 2014 Aug; 38(8):e6-e19. PubMed ID: 25029122
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic utility of p501s (prostein) in comparison to prostate specific antigen (PSA) for the detection of metastatic prostatic adenocarcinoma.
Yin M; Dhir R; Parwani AV
Diagn Pathol; 2007 Oct; 2():41. PubMed ID: 17963516
[TBL] [Abstract][Full Text] [Related]
9. Aberrant GATA3 Staining in Prostatic Adenocarcinoma: A Potential Diagnostic Pitfall.
McDonald TM; Epstein JI
Am J Surg Pathol; 2021 Mar; 45(3):341-346. PubMed ID: 32769430
[TBL] [Abstract][Full Text] [Related]
10. Pseudopapillary features in prostatic adenocarcinoma mimicking urothelial carcinoma: a diagnostic pitfall.
Gordetsky J; Epstein JI
Am J Surg Pathol; 2014 Jul; 38(7):941-5. PubMed ID: 24503758
[TBL] [Abstract][Full Text] [Related]
11. Performance of different prostate specific antibodies in the cytological diagnosis of metastatic prostate adenocarcinoma.
Jia L; Jiang Y; Michael CW
Diagn Cytopathol; 2017 Nov; 45(11):998-1004. PubMed ID: 28888085
[TBL] [Abstract][Full Text] [Related]
12. Clinicopathologic Study of Gleason Pattern 5 Prostatic Adenocarcinoma With "Single-cell" Growth Reveals 2 Distinct Types, One With "Plasmacytoid" Features.
Nguyen JK; Chen YY; Magi-Galluzzi C; McKenney JK
Am J Surg Pathol; 2020 Dec; 44(12):1635-1642. PubMed ID: 32991340
[TBL] [Abstract][Full Text] [Related]
13. Small cell carcinoma of the prostate. A morphologic and immunohistochemical study of 95 cases.
Wang W; Epstein JI
Am J Surg Pathol; 2008 Jan; 32(1):65-71. PubMed ID: 18162772
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of SF-1 expression in testicular germ cell tumors: a tissue microarray study of 127 cases.
Sangoi AR; McKenney JK; Brooks JD; Higgins JP
Appl Immunohistochem Mol Morphol; 2013 Jul; 21(4):318-21. PubMed ID: 23165333
[TBL] [Abstract][Full Text] [Related]
15. An unusual variant of prostatic adenocarcinoma with metastasis to testis. A case report.
Anila KR; Somanathan T; Mathews A; Jayasree K
Gulf J Oncolog; 2012 Jul; (12):73-6. PubMed ID: 22773221
[TBL] [Abstract][Full Text] [Related]
16. Utility of NKX3.1 Immunostaining in the Detection of Metastatic Prostatic Carcinoma on Fine-Needle Aspiration Smears.
Gan Q; Joseph CT; Guo M; Zhang M; Sun X; Gong Y
Am J Clin Pathol; 2019 Sep; 152(4):495-501. PubMed ID: 31175351
[TBL] [Abstract][Full Text] [Related]
17. Metastasis of prostate adenocarcinoma to testis.
Baykal K; Yildirim S; Inal H; Kalci E; Albayrak S; Cingil H; Onol Y
Int J Urol; 1997 Jan; 4(1):104-5. PubMed ID: 9179680
[TBL] [Abstract][Full Text] [Related]
18. Differential expression of NKX 3.1 and HOXB 13 in bone metastases originating from prostatic carcinoma among the Egyptian males.
Abouhashem NS; Salah S
Pathol Res Pract; 2020 Oct; 216(10):153221. PubMed ID: 32979741
[TBL] [Abstract][Full Text] [Related]
19. Utility of NKX3.1 immunohistochemistry in the differential diagnosis of seminal vesicles versus prostatic tissue in needle biopsy.
Pitra T; Pivovarcikova K; Alaghehbandan R; Compérat EM; Hora M; Rogala J; Slisarenko M; Michal M; Hes O
Ann Diagn Pathol; 2020 Dec; 49():151644. PubMed ID: 33126153
[TBL] [Abstract][Full Text] [Related]
20. SOCS3 Immunohistochemical Expression Seems to Support the 2005 and 2014 International Society of Urological Pathology (ISUP) Modified Gleason Grading System.
Pierconti F; Martini M; Cenci T; Petrone GL; Ricci R; Sacco E; Bassi PF; Larocca LM
Prostate; 2017 May; 77(6):597-603. PubMed ID: 28144985
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
